Nguyen BN, Mital S, Bugden S, Nguyen HV, et al. Cost-effectiveness of canagliflozin and dapagliflozin for treatment of patients with chronic kidney disease and type 2 diabetes. Diabetes Obes Metab 2023 Jul 6. doi: 10.1111/dom.15201.
PMID: 37409571